# EHRA-PATHS: Clinical and Health Economic Evaluation of New Care Pathways

Study · id `cardio:ct-nct05773768` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05773768](<https://clinicaltrials.gov/study/NCT05773768>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05773768

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 703 participants.

## Technical summary

Registry record NCT05773768. Randomized; no masking; primary purpose diagnostic. Start 2024-03-28 (actual); primary completion 2026-07-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 703 participants (enrolled count; ClinicalTrials.gov record NCT05773768, source copy `cardio:ctgov-nct05773768-2026-09-28`, retrieved 2026-10-26)
- Started: 2024-03-28 (actual) (ClinicalTrials.gov record NCT05773768, source copy `cardio:ctgov-nct05773768-2026-09-28`, retrieved 2026-10-26)
- Primary completion: 2026-07-01 (actual) (ClinicalTrials.gov record NCT05773768, source copy `cardio:ctgov-nct05773768-2026-09-28`, retrieved 2026-10-26)
- Completion: 2026-07-01 (actual) (ClinicalTrials.gov record NCT05773768, source copy `cardio:ctgov-nct05773768-2026-09-28`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT05773768, source copy `cardio:ctgov-nct05773768-2026-09-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05773768-2026-09-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: EHRA-PATHS: Clinical and Health Economic Evaluation of New Care Pathways
- Acronym: EHRA-PATHS
- Condition: Atrial Fibrillation
- Intervention (Device): EHRA-PATHS software tool
- Lead sponsor: University Medical Center Groningen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: University Medical Center Groningen (`cardio:org-university-medical-center-groningen`)

## Provenance

Content hash: 51f9e70ee93f62a1d2686e1c35c19cc3651416583a7c842618bc5ce09bdd6efc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
